A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.

BACKGROUND: β-Microseminoprotein (MSP) is one of the three most abundantly secreted proteins of the prostate and has been suggested as a biomarker for prostate cancer risk. A common variant, rs10993994, in the 5' region of the gene that encodes MSP (MSMB) has recently been identified as a risk...

Cijeli opis

Bibliografski detalji
Glavni autori: Waters, K, Stram, DO, Le Marchand, L, Klein, R, Valtonen-André, C, Peltola, M, Kolonel, L, Henderson, B, Lilja, H, Haiman, C
Format: Journal article
Jezik:English
Izdano: 2010
_version_ 1826297306246283264
author Waters, K
Stram, DO
Le Marchand, L
Klein, R
Valtonen-André, C
Peltola, M
Kolonel, L
Henderson, B
Lilja, H
Haiman, C
author_facet Waters, K
Stram, DO
Le Marchand, L
Klein, R
Valtonen-André, C
Peltola, M
Kolonel, L
Henderson, B
Lilja, H
Haiman, C
author_sort Waters, K
collection OXFORD
description BACKGROUND: β-Microseminoprotein (MSP) is one of the three most abundantly secreted proteins of the prostate and has been suggested as a biomarker for prostate cancer risk. A common variant, rs10993994, in the 5' region of the gene that encodes MSP (MSMB) has recently been identified as a risk factor for prostate cancer. METHODS: We examined the association between rs10993994 genotype and MSP levels in a sample of 500 prostate cancer-free men from four racial/ethnic populations in the Multiethnic Cohort (European Americans, African Americans, Latinos, and Japanese Americans). Generalized linear models were used to estimate the association between rs10993994 genotype and MSP levels. RESULTS: We observed robust associations between rs10994994 genotype and MSP levels in each racial/ethnic population (all P < 10(-8)), with carriers of the C allele having lower geometric mean MSP levels (ng/mL; CC/CT/TT genotypes: European Americans, 28.8/20.9/10.0; African Americans, 29.0/21.9/10.9; Latinos, 29.2/17.1/8.3; and Japanese Americans, 25.8/16.4/6.7). We estimated the variant accounts for 30% to 50% of the variation in MSP levels in each population. We also observed significant differences in MSP levels between populations (P = 3.5 × 10(-6)), with MSP levels observed to be highest in African Americans and lowest in Japanese Americans. CONCLUSIONS: Rs10993994 genotype is strongly associated with plasma MSP levels in multiple racial/ethnic populations. IMPACT: This supports the hypothesis that rs10993994 may be the biologically functional allele.
first_indexed 2024-03-07T04:29:34Z
format Journal article
id oxford-uuid:cdda3a3b-2b05-4c74-9233-9f66b0fc6b11
institution University of Oxford
language English
last_indexed 2024-03-07T04:29:34Z
publishDate 2010
record_format dspace
spelling oxford-uuid:cdda3a3b-2b05-4c74-9233-9f66b0fc6b112022-03-27T07:31:32ZA common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cdda3a3b-2b05-4c74-9233-9f66b0fc6b11EnglishSymplectic Elements at Oxford2010Waters, KStram, DOLe Marchand, LKlein, RValtonen-André, CPeltola, MKolonel, LHenderson, BLilja, HHaiman, CBACKGROUND: β-Microseminoprotein (MSP) is one of the three most abundantly secreted proteins of the prostate and has been suggested as a biomarker for prostate cancer risk. A common variant, rs10993994, in the 5' region of the gene that encodes MSP (MSMB) has recently been identified as a risk factor for prostate cancer. METHODS: We examined the association between rs10993994 genotype and MSP levels in a sample of 500 prostate cancer-free men from four racial/ethnic populations in the Multiethnic Cohort (European Americans, African Americans, Latinos, and Japanese Americans). Generalized linear models were used to estimate the association between rs10993994 genotype and MSP levels. RESULTS: We observed robust associations between rs10994994 genotype and MSP levels in each racial/ethnic population (all P < 10(-8)), with carriers of the C allele having lower geometric mean MSP levels (ng/mL; CC/CT/TT genotypes: European Americans, 28.8/20.9/10.0; African Americans, 29.0/21.9/10.9; Latinos, 29.2/17.1/8.3; and Japanese Americans, 25.8/16.4/6.7). We estimated the variant accounts for 30% to 50% of the variation in MSP levels in each population. We also observed significant differences in MSP levels between populations (P = 3.5 × 10(-6)), with MSP levels observed to be highest in African Americans and lowest in Japanese Americans. CONCLUSIONS: Rs10993994 genotype is strongly associated with plasma MSP levels in multiple racial/ethnic populations. IMPACT: This supports the hypothesis that rs10993994 may be the biologically functional allele.
spellingShingle Waters, K
Stram, DO
Le Marchand, L
Klein, R
Valtonen-André, C
Peltola, M
Kolonel, L
Henderson, B
Lilja, H
Haiman, C
A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title_full A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title_fullStr A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title_full_unstemmed A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title_short A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
title_sort common prostate cancer risk variant 5 of microseminoprotein beta msmb is a strong predictor of circulating beta microseminoprotein msp levels in multiple populations
work_keys_str_mv AT watersk acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT stramdo acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT lemarchandl acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT kleinr acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT valtonenandrec acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT peltolam acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT kolonell acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT hendersonb acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT liljah acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT haimanc acommonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT watersk commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT stramdo commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT lemarchandl commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT kleinr commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT valtonenandrec commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT peltolam commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT kolonell commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT hendersonb commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT liljah commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations
AT haimanc commonprostatecancerriskvariant5ofmicroseminoproteinbetamsmbisastrongpredictorofcirculatingbetamicroseminoproteinmsplevelsinmultiplepopulations